Divarasib: clinical trials recruiting now
4
Recruiting trials
5
Conditions studied
29
US states with sites
30
Countries
Phase breakdown
Phase 1 2
Phase 2 1
Phase 3 2
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer · Divarasib for Lung cancer | 3 |
| Non-Small Cell Lung Cancer · Divarasib for Non-Small Cell Lung Cancer | 3 |
| Colorectal cancer | 1 |
| KRAS G12C Lung Cancer | 1 |
| Metastatic Colorectal Cancer | 1 |
Recruiting trials involving Divarasib
- A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
- A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
Common questions
How many recruiting trials involve Divarasib?
4 recruiting trials across 5 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.